Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
1996
ISSN/ISBN: 0385-0684 PMID: 8645033 Document Number: 458084
Document emailed within 1 workday
Related Documents
Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44Merli, F.; Federico, M.; Avanzini, P.; Ilariucci, F.; Stelitano, C.; Iannitto, E.; Colombi, M.; Vallisa, D.; Santagati, G.; Picinini, L. 1998: Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi Haematologica 83(3): 217-221
Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3
Taguchi, H.; Shishido, T.; Niitsu, N.; Hiraoka, A.; Kageyama, T.; Kanamaru, A.; Ogawa, M. 1998: High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 523-529
Brice, P.; Lepage, E.; Gisselbrecht, C.; Fior, R.; Trédaniel, J.; d'Agay, M.F.; Boiron, M. 1990: Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatment Nouvelle Revue Francaise D'hematologie 32(2): 153-157
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Rolski, J.; Koralewski, P.; Pawlicki, M. 1993: Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma Wiadomosci Lekarskie 46(9-10): 356-359
Salminen, E. 1994: The treatment of non-Hodgkin lymphoma in elderly patients Duodecim; Laaketieteellinen Aikakauskirja 110(21): 1993-1998
Hołowiecki, J.; Giebel, S.; Walewski, J.; Krawczyk-Kuliś, M.łg.; Hellmann, A.; Skotnicki, A.; Dmoszyńska, A.; Romejko, J.; Czyz, J.ła.; Jurczak, W.; Kachel, Łu.; Wojnar, J.; Stella-Hołowiecka, B.; Saduś-Wojciechowska, M.; Sułek, K.; Jedrzejczak, W.ła.; Robak, T.; Mariańska, B.; Szczylik, C.; Warzocha, K. 2003: Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. the experience of Polish lymphoma research group Polskie Archiwum Medycyny Wewnetrznej 110(2): 863-868
Doorduijn, J.K.; Sonneveld, P. 1997: Diagnosis and treatment of non-Hodgkin lymphoma in elderly patients Nederlands Tijdschrift Voor Geneeskunde 141(45): 2152-2157
Morrison, V.A. 2007: Non-Hodgkin's lymphoma in the elderly. Part 1: Overview and treatment of follicular lymphoma Oncology 21(9): 1104-1110
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740
Landgren, O.; Algernon, C.; Axdorph, U.; Nilsson, B.; Wedelin, C.; Porwit-MacDonald, A.; Grimfors, G.; Björkholm, M. 2003: Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis Haematologica 88(4): 438-444
Durant, J.R.; Gams, R.A.; Bartolucci, A.A.; Dorfman, R.F. 1977: BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma Cancer Treatment Reports 61(6): 1085-1096
Armitage, J.O. 2005: The treatment of patients with aggressive non-Hodgkin's lymphoma Oncology 19(4 Suppl 1: 3-6
Carpentieri, U.; Lockhart, L.H. 1978: Ataxia and athetosis as side effects of chemotherapy with vincristine in non-Hodgkin's lymphoma Cancer Treatment Reports 62(4): 561-562
Davidson, K.L.; Devaney, M.B.; Tighe, J.E.; Rogers, S.Y.; Dunlop, D.J.; Mackie, M.J.; Thomas, R.V.; Johnson, P.R.E. 2003: A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study Haematologica 88(12): 1366-1371
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Coiffier, B. 2008: The challenges of Hodgkin lymphoma in the elderly Oncology 22(12): 1388; 1393